Dr. Frauke Mücksch
Department of Infectious Diseases, Virology
Schaller Research Group
Heidelberg University Hospital
69120 Heidelberg, Germany
Phone: +49 6221-56 5003
E-Mail
FIELDS OF INTEREST
Molecular virology, immuno- and cell biology of HIV infection; mechanisms of HIV latency establishment, maintenance and reversal;
molecular biology of resistance to latency reversing agents; virus-host interaction
AWARDS & HONORS
2021 Group Leader fellowship, CHS Stiftung
2020 – 2021 Bulgari Women & Science Fellowship in COVID-19 Research
| 2022-present | Chica-and-Heinz Schaller group leader at Heidelberg University |
| 2019-2022 | Postdoctoral associate, The Rockefeller University, New York |
| 2018-2019 | Postdoctoral associate, Department of Virology, Heidelberg University Hospital |
| 2013-2017 | PhD student, Department of Virology, Heidelberg University Hospital |
| 2011-2013 | Studies of Biomedical Science (University of Marburg) |
| 2008-2011 | Studies of Biology (Goethe University Frankfurt) |
| 2023 – | Mitglied der Forschungskommission der Medizinischen Fakultät Heidelberg |
peer-reviewed publications (*designates multiple first authors)
Muecksch F*, Wang Z*, Cho A*, Gaebler C, Ben Tanfous T, DaSilva J, Bednarski E, Ramos V, Zong S, Johnson B, Raspe R, Schaefer-Babajew D, Shimeliovich I, Daga M, Yao KH, Schmidt F, Millard KG, Turroja M, Jankovic M, Oliveira TY, Gazumyan A, Caskey M, Hatziioannou T, Bieniasz PD, Nussenzweig MC. Increased Memory B Cell Potency and Breadth After a SARS-CoV-2 mRNA Boost. Nature (2022)
Muecksch F, Wise H*, Templeton K, Batchelor B, Squires M, McCance K, Jarvis L, Malloy K, Furrie E, Richardson C, MacGuire J, Godber I, Burns A, Mavin S, Zhang F, Schmidt F, Bieniasz PD, Jenks S, Hatziioannou T. Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis. Lancet Microbe. 2022 May 27;3(7):e493-502 (2022).
Cho A*, Muecksch F*, Schaefer-Babajew D*, Wang Z*, Finkin S*, Gaebler C, Ramos V, Cipolla M, Mendoza P, Agudelo M, Bednarski E, DaSilva E, Shimeliovich I, Dizon J, Daga M, Millard K, Turroja M, Schmidt F, Zhang F, Tanfous TB, Jankovic M, Oliveria TY, Gazumyan A, Caskey M, Bieniasz PD, Hatziioannou T, Nussenzweig MC. 2021. Anti-SARS-CoV-2 receptor binding domain antibody evolution after mRNA vaccination. Nature. https://doi.org/10.1038/s41586-021-04060-7
Muecksch F*, Weisblum Y*, Barnes CO*, Schmidt F*, Schaefer-Babajew D, Wang Z, C Lorenzi JC, Flyak AI, DeLaitsch AT, Huey-Tubman KE, Hou S, Schiffer CA, Gaebler C, Da Silva J, Poston D, Finkin S, Cho A, Cipolla M, Oliveira TY, Millard KG, Ramos V, Gazumyan A, Rutowska M, Caskey M, Nussenzweig MC, Bjorkman PJ, Hatziioannou T, Bieniasz PD. 2021. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity. 54:1853-1868
Wang Z*, Muecksch F*, Schaefer-Babajew D*, Finkin S*, Viant C*, Gaebler C*, Hoffmann H-H, Barnes CO, Cipolla C, Ramos V, Oliveira TY, Cho A, Schmidt F, da Silva J, Bednarski E, Aguado L, Yee J, Daga M, Turroja M, Millard KG, Jankovic M, Gazumyan A, Zhao Z, Rice CM, Bieniasz PD, Caskey M, Hatziioannou T, Nussenzweig MC. 2021. Naturally enhanced neutralizing breadth to SARS-CoV-2 one year after infection. Nature. 595:426-431
Bou-Nader C*, Muecksch F*, Brown J, Gordon JM, York A, Peng C, Ghirlando R, Summers MF, Bieniasz PD, Zhang J. 2021. Structural basis for host tRNA control of HIV-1 Gag localization. Cell Host Microbe. 29(9):1421-1436
Gaebler C*, Wang Z*, C Lorenzi JC*, Muecksch F*, Finkin S*, Tokuzama M*, Cho A*, Jankovic M*, Schaefer-Babajew D*, Oliveira TY*, Cipolla M*, Viant C, Barnes CO, Bran Y, Breton G, Haegloef T, Mendoza P, Hurley A, Turroja M, Gordon K, Millard KG, Ramos V, Schmidt F, Weisblum Y, Jha D, Tankelevich M, Martinez-Delgado G, Yee J, Patel R, Dizon J, Unson-O’Brien C, Shimeliovich I, Robbiani DF, Zhao Z, Gazumyan A, Schwartz RT, Hatiionannou T, Bjorkman PM, Mehandru S, Bieniasz PD, Caskey M, Nussenzweig MC. 2021. Evolution of antibody immunity to SARS-CoV-2. Nature. 591:639-644
Robbiani DF*, Gaebler C*, Muecksch F*, C Lorenzi JC*, Wang Z*, Cho A*, Agudelo M*, Barnes CO*, Gazumyan A*, Finkin S*, Hägglöf S*, Oliveira TY*, Viant C*, Hurley A, Hoffmann H-H, Millard KG, Kost RG, Cipolla M, Gordon K, Bianchini F, Chen ST, Ramos V, Patel R, Dizon J, Shimeliovich I, Mendoza P, Hartweger H, Nogueira L, Pack M, Horowitz J, Schmidt F, Weisblum Y, Michailidis E, Ashbrook AW, Waltari E, Pak JE, Huey-Tubman KE, Koranda N, Hoffman PR, West Jr AP, Rice CM, Hatziioannou T, Bjorkman PJ, Bieniasz PD, Caskey M, Nussenzweig MC. 2020. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584:437-422
Mücksch F*, Citir M*, Lüchtenborg C, Glass B, Traynor-Kaplan A, Schultz C, Brügger B, Kräusslich HG. 2019. Quantification of phosphoinositides reveals strong enrichment of PIP2 in HIV-1 compared to producer cell membranes. Sci Rep 9:17661
Mücksch F, Laketa V, Müller B, Schultz C, Kräusslich HG. 2017. Synchronized HIV assembly by tunable PIP2 changes reveals PIP2 requirement for stable Gag anchoring. eLife 6:e2528
Click here for further publications.